FIELD: biotechnology.
SUBSTANCE: invention relates to pharmacology, namely to use of bromide 2-benzyl-1-morpholinoethyl-3-pivaloylmethylbenzimidazole of formula I 
as the cardiotonic active compound, including for production of the cardiotonic preparation.
EFFECT: increasing cardiotonic activity.
2 cl, 6 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
| AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
| METHOD OF CARDIOPROTECTIVE ACTIVITY ESTIMATION OF PHARMACOLOGICAL FACILITIES | 2017 |
|
RU2643104C1 |
| PLANT-DERIVED AGENT WITH CARDIOTONIC ACTIVITY IN CHRONIC HEART FAILURE | 2017 |
|
RU2654706C1 |
| 5-POTASSIUM HYDROXINICOTINATE WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2640580C1 |
| 2-(1-(2-(2-CHLORO-10H-PHENOTHIAZIN-10-YL)-2-OXOETHYL)-5-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENOL, HAVING HYPOTENSIVE AND ANTIARRHYTHMIC ACTIVITY | 2008 |
|
RU2394823C2 |
| METHOD FOR PREVENTING AND TREATING MYOCARDIAL ISCHEMIA | 2002 |
|
RU2241463C2 |
| CARDIOTONIC AND HYPERTENSIVE AGENT WITH PROLONGED HYPERTENSION EFFECT AND MEDICINAL FORMS BASED ON THEREOF | 1999 |
|
RU2181286C2 |
| METHOD OF TREATING ACUTE LEFT VENTRICULAR INSUFFICIENCY OF I-III CLASS IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2423115C2 |
| AGENT POSSESSING CARDIO-, NEPHRO-, ENDOTHELIAL-, MICROANGIO-, MACROANGIO- AND ENCEPHALOPROTECTIVE PROPERTIES | 2018 |
|
RU2700791C1 |
